Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

“Optilume exhibited a significant improvement in [the primary] objective outcome at 6 months and subjective outcomes at 1-year post treatment compared to standard of...

The role of urologists in working with medical oncologists to treat patients with advanced prostate cancer, with special considerations for early...

“As a committee, we felt that there was a need to put together a document to help field some of the ethical considerations that...

“Qmax at 1, 3, 6, 9, and 12 months and voiding volume at 3 months were significantly lower in the impaired group than in...

“Optilume exhibited a significant improvement in [the primary] objective outcome at 6 months and subjective outcomes at 1-year post treatment compared to standard of...

“Being a patient has convinced me that providers do not always treat patients the way they would want to be treated,” writes Robert A....

“Ideally…we have a technology that’s noninvasive that we can use in the clinic, where they don’t require any anesthesia to…break the stones and make...

“I think another good take-home message is the importance of the informed consent process,” says Una Lee,...

“What stood out for me in prostate cancer is the new imaging opportunities for patients with advanced prostate cancer or prostate cancer recurrence,” says...

Julie N. Graff, MD, of OHSU Knight Cancer Institute, comments on the impact of the availability of newer-generation androgen receptor inhibitors on treatment outcomes...